1. Home
  2. NTHI vs RMMZ Comparison

NTHI vs RMMZ Comparison

Compare NTHI & RMMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeOnc Technologies Holdings Inc.

NTHI

NeOnc Technologies Holdings Inc.

HOLD

Current Price

$3.44

Market Cap

114.6M

Sector

Health Care

ML Signal

HOLD

Logo RiverNorth Managed Duration Municipal Income Fund II Inc.

RMMZ

RiverNorth Managed Duration Municipal Income Fund II Inc.

HOLD

Current Price

$14.65

Market Cap

125.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTHI
RMMZ
Founded
2008
N/A
Country
United States
United States
Employees
5
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
114.6M
125.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NTHI
RMMZ
Price
$3.44
$14.65
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
65.4K
16.3K
Earning Date
05-19-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.01
$13.91
52 Week High
$12.99
$15.29

Technical Indicators

Market Signals
Indicator
NTHI
RMMZ
Relative Strength Index (RSI) 35.86 34.39
Support Level $3.01 $14.61
Resistance Level $4.59 $15.11
Average True Range (ATR) 0.38 0.16
MACD -0.03 -0.04
Stochastic Oscillator 25.55 10.98

Price Performance

Historical Comparison
NTHI
RMMZ

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

About RMMZ RiverNorth Managed Duration Municipal Income Fund II Inc.

RiverNorth Managed Duration Municipal Income Fund II Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.

Share on Social Networks: